| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRC75B | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ERICH3 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | ZNF644 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | C7orf26 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | IRF2BP2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | ZKSCAN8 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | SUPT7L | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | SARAF | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | CHRNB3 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | CHMP3 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.08 |
